Drugs / Grass pollen allergenic extract (L. perenne-C. dactylon )
Grass pollen allergenic extract (L. perenne-C. dactylon )
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00550875 | Jun 2007 → Dec 2009 | allergic disease | Laboratorios Leti, S.L. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Grass pollen allergenic extract (L. perenne-C. dactylon ) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00550875 ↗ |
| Modality | Vaccine | “The study drug is a sublingual immunotherapy (vaccine) with allergenic extract of grass pollen” NCT00550875 ↗ |